Hyloris On Track To Meet 2024 Target During Half-Year Update

Company Aims To Expand Its Portfolio To 30 Products By 2024

Train approaching train station on top of Mount Rigi in canton of Schwyz, Switzerland
Hyloris remains on track to meet its 2024 ambitions, according to the company's CEO • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business